Molecular Diagnostic for Infectious Diseases Market Forecast (2023-2030)
传染病分子诊断市场规模预计将从 2022 年的 68.8303 亿美元增至 2030 年的 176.1444 亿美元。预计 2022-2030 年期间该市场的复合年增长率将达到 12.5%。个性化医疗中传染病分子诊断可能仍是市场的主要趋势。
传染病分子诊断市场分析
推动市场发展的因素包括全球传染病患病率的飙升以及分子诊断在兽医传染病中的应用日益广泛。此外,模拟教育意识的提高为传染病分子诊断市场在未来预测期内创造了增长机会。妇科疾病的增加推动了对妇科设备的需求,包括卵巢癌、宫颈癌、子宫癌、阴道癌和外阴癌。根据美国癌症协会 2022 年的更新,女性通常在 60 岁时被诊断出患有子宫内膜癌。然而,45 岁之前的诊断并不常见。
传染病分子诊断市场概况
传染病对公共卫生造成不利影响,导致发病率、死亡率和经济负担。传染病呈上升趋势,需要准确及时的诊断,以便为有效的疾病管理、治疗和预防奠定基础。可以使用分子诊断技术、实验室检测和即时检测来诊断和监测多种感染和疾病——包括艾滋病毒、结核病、丙型肝炎、宫颈癌的人乳头瘤病毒筛查和性传播感染以及感染爆发。根据 2021 年美国国家医学图书馆 (NLM) 发表的一篇文章,由于医疗资源有限和疾病负担沉重,传染病是大多数非洲国家面临的重大问题。在尼日利亚,有 200 多种病原体可引起发烧,这是就诊最常见的原因之一。这些病原体包括疟疾寄生虫、肠道沙门氏菌和出血性病毒。仅凭培养结果无法可靠地检测出危及生命的病原体。因此,在传染病负担较高的地区,有效的分子诊断至关重要。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
传染病分子诊断市场:
复合年增长率(2022 - 2030 年)12.5%- 2022 年市场规模
68.8 亿美元 - 2030 年市场规模
176.1 亿美元
![Insight Partners - 徽标](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
市场动态
- 传染病发病率飙升,推动了对分子诊断技术的需求,而非传统技术
- 个性化医疗中传染病的分子诊断可能仍是市场的主要趋势
- 不同国家科学界为控制传染病而开展的合作努力可能会为市场创造重大机遇
关键人物
- 霍夫曼-罗氏公司
- 雅培实验室
- 赛默飞世尔科技公司
- 生物梅里埃公司
- 丹纳赫公司
- 霍洛吉奇公司
- 西门子医疗股份公司
- 布鲁克公司
- 莫尔兹姆有限公司
- 迪亚索林公司
区域概况
![区域概况](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
![市场细分](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- 即时检验
- 实验室测试
![市场细分](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 即时检验
- 实验室测试
![市场细分](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- 即时检验
- 实验室测试
![市场细分](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 即时检验
- 实验室测试
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
传染病分子诊断市场驱动因素和机遇
分子诊断在兽医传染病领域的应用日益广泛
能够及早发现新发传染病的诊断技术对于减少此类疾病爆发造成的经济损失至关重要。聚合酶链反应 (PCR) 仍然是全球最广泛使用的检测动物病原体的分子检测方法。此类诊断方法易于使用、经济高效、敏感且特异性强,能够进行大量检测。
即时诊断 (POCD) 是一种简单、快速且便携的诊断设备,可在现场检测疾病状态。近年来,实时 PCR (qPCR) 已转变为 POCD 平台。这些全自动平台结合了核酸提取、热循环和现场报告结果。例如,Enigma Diagnostics 的 MiniLab 是一个 10-35 公斤的分子诊断平台,可在现场携带,用于验证非洲猪瘟病毒、禽流感病毒、猪瘟病毒和口蹄疫病毒以用于研究目的。因此,用于诊断动物细菌、病毒、真菌和寄生虫感染的 PCR 和 qPCR 等分子诊断方法可以取代血清学、显微镜和基于培养的技术等传统方法。
分子诊断技术的进步
遗传和基因组研究促进了以核酸检测为重点的分子诊断技术的发展,为快速检测传染病提供了新方法。分子诊断技术可检测多种病原体,并分析病原体的耐药基因和病原体同源性分析,使其成为早期诊断传染病越来越重要的工具。分子诊断技术和平台用于解剖和临床病理学的所有领域。与疾病相关的 DNA 或 RNA 序列,包括单核苷酸多态性、缺失、重排和插入,都可以通过分子诊断测试检测出来。传统上,CT 扫描、血液学测试和逆转录-PCR (RT-PCR) 用于测试。由于传染病的增多,对快速、精确的测试平台的需求激增,以克服传统测试的缺点。不同国家的科学界为管理传染病和降低死亡率而做出的合作努力使整个分子工具和诊断领域受益,这可能会为未来传染病分子诊断市场创造重大机遇。
传染病分子诊断市场报告细分分析
有助于得出传染病分子诊断市场分析的关键部分是产品和最终用户。
- 根据类型,传染病分子诊断市场细分为即时检测、实验室检测。实验室检测部分在 2022 年占据了更大的市场份额。
- 根据应用,传染病分子诊断市场细分为即时检测、实验室检测。实验室检测部分在 2022 年占据了更大的市场份额。
- 根据疾病类型,传染病分子诊断市场细分为即时检测和实验室检测。实验室检测部分在 2022 年占据了更大的市场份额。
- 根据感染类型,传染病分子诊断市场细分为即时检测和实验室检测。实验室检测部分在 2022 年占据了更大的市场份额。
- 根据最终用户,传染病分子诊断市场可分为即时检测和实验室检测。实验室检测部分在 2022 年占据了更大的市场份额。
传染病分子诊断市场份额地域分析
传染病分子诊断市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。
北美传染病分子诊断市场已细分为美国、加拿大和墨西哥。推动北美传染病分子诊断市场增长的关键因素包括技术先进产品的日益普及、研发活动的增加、大型医疗保健企业的存在以及分子诊断试剂盒在传染病诊断中的日益广泛使用。美国传染病分子诊断市场的增长主要受传染病患病率上升、老年人口增加以及主要参与者推出多种产品所驱动。衰老是肾脏疾病的一个突出风险因素。根据人口参考局 2020 年发布的一项研究,2020 年美国 65 岁及以上人口为 5500 万,预计到 2060 年这一数字将上升至 9500 万。美国监管机构正在制定有利政策,以开发用于诊断和治疗各种适应症的即时诊断 (POC) 产品。
传染病分子诊断市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 68.8亿美元 |
2030 年的市场规模 | 176.1亿美元 |
全球复合年增长率(2022 - 2030 年) | 12.5% |
史料 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
传染病分子诊断市场新闻和最新发展
传染病分子诊断市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。传染病分子诊断市场的一些发展如下所列:
- 赛默飞世尔科技在印度推出用于检测传染病的 PCR 试剂盒。赛默飞世尔科技宣布,其用于检测耐多药结核病 (MTB MDR)、结核分枝杆菌复合体 (MTB)、乙型肝炎病毒 (HBV)、丙型肝炎病毒 (HCV)、人类免疫缺陷病毒 (HIV) 等传染病和用于基因分析 (HLA B27) 的 Applied Biosystems TaqPath PCR 试剂盒已获得印度中央药品标准控制组织 (CDSCO) 的许可权,并将与 Mylab Discovery Solutions 合作在印度生产。(来源:赛默飞世尔科技公司,公司网站,2023 年 2 月)
- 布鲁克推出用于 MALDI Biotyper 的新型分枝杆菌和真菌 IVD 解决方案,以及新型 LiquidArray 胃肠道综合征面板。随着分枝杆菌和真菌的新 IVD 工作流程、试剂盒、软件和参考库的推出,该公司进一步扩展了成熟的 MALDI Biotyper 平台的应用。这为所有现有和未来的客户创造了额外的价值。新的 LiquidArray Gastrointestinal 是一种具有惊人病原体覆盖率的下一代综合征面板。它非常适合那些对广泛筛查方法感兴趣的实验室,以便在一次运行中检测出大多数病原体。(来源:布鲁克公司,公司网站,2023 年 4 月)
传染病分子诊断市场报告覆盖范围和交付成果
“传染病分子诊断市场规模和预测(2020-2030 年)”报告对以下领域进行了详细的市场分析:
- 传染病分子诊断市场规模及全球、区域和国家层面所有主要细分市场的预测
- 传染病分子诊断市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 传染病分子诊断市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及传染病分子诊断市场的最新发展
- 详细的公司简介
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the market include surging prevalence of infectious disease globally and rising application of molecular diagnostics in veterinary infectious diseases. However, limitations associated with molecular testing hinders the market growth.
F.Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, bioMerieux SA, Danaher Corp, Hologic Inc, Siemens Healthineers AG, Bruker Corp, Molzym GmbH & Co KG, and DiaSorin SpA.
North America dominated the molecular diagnostic for infectious diseases market in 2022
The market is expected to register a CAGR of 12.5% during 2022–2030.
Molecular diagnostics for infectious diseases in personalized medicine is likely to remain a key trend in the market.
The List of Companies - Molecular Diagnostics for Infectious Diseases Market
- F. Hoffmann-La Roche Ltd
- Abbott
- Thermo Fisher Scientific Inc
- bioMérieux SA
- Danaher
- Digene and International Murex Technologies
- Hologic
- Siemens Healthcare Private Limited
- Bruker Corporation
- Molzym
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.